ARTICLE | Product Development
Roche broadens its BD scope
James Sabry on what Spark deal says about Roche’s future BD strategy
March 2, 2019 1:10 AM UTC
Roche’s proposed acquisition of Spark Therapeutics Inc. is the pharma’s first major deal since James Sabry took over partnering, and could be a glimpse of what’s to come as the pharma broadens its horizons on indications and modalities.
On Feb. 25, Roche announced it would acquire Spark for $4.8 billion in cash...